Literature DB >> 2674770

MR imaging of cerebral tumors: state of the art and work in progress.

H P Higer1, P Pedrosa, M Schuth.   

Abstract

MR imaging of the brain has made tremendous progress during the last years. This technique is generally superior to computed tomography (CT) in brain tumors, due to its capability for direct imagining in various planes and its high tissue contrast. Moreover, the detectability and differentiation of extraaxial tumors, previously the domain of CT, has been improved with paramagnetic contrast agents (PCA). Although, the sensitivity of MRI for intracranial tumors is unchallenged, the specificity for such tumors is not remarcably greater than that of CT. Differentiation between high grade glioma, abscess and metastasis still requires biopsy for definitive diagnosis. Methods for improvement of specificity--tissue characterization--are currently being evaluated in a clinical setting. Further development in this field is necessary before such methods can be applied on a routine basis.

Entities:  

Mesh:

Year:  1989        PMID: 2674770     DOI: 10.1007/bf01741480

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  47 in total

1.  [MR tomography of benign brain tumors].

Authors:  M Just; H P Higer; G Vahldiek; J Bohl; S Kunze; O Hey; P Pfannenstiel
Journal:  Rofo       Date:  1987-10

2.  [Tissue characterization with T1, T2 and proton density: dream and reality].

Authors:  H P Higer; G Bielke
Journal:  Rofo       Date:  1986-05

3.  Strategy for NMR exploration of brain tumours. Usefulness of the multiple echo technique.

Authors:  A Debaene; J Lavieille; J F Stanoyevitch; J Legre
Journal:  J Neuroradiol       Date:  1985       Impact factor: 3.447

Review 4.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic?

Authors:  P A Bottomley; C J Hardy; R E Argersinger; G Allen-Moore
Journal:  Med Phys       Date:  1987 Jan-Feb       Impact factor: 4.071

5.  Benign extraaxial tumors: contrast enhancement with Gd-DTPA.

Authors:  R K Breger; R A Papke; K W Pojunas; V M Haughton; A L Williams; D L Daniels
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

6.  MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values.

Authors:  M Komiyama; H Yagura; M Baba; T Yasui; A Hakuba; S Nishimura; Y Inoue
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jan-Feb       Impact factor: 3.825

7.  Dynamic MR imaging: a further possibility for characterizing CNS lesions.

Authors:  F Koschorek; H P Jensen; B Terwey
Journal:  AJNR Am J Neuroradiol       Date:  1987 Mar-Apr       Impact factor: 3.825

8.  Intracerebral malignant melanoma: high-field-strength MR imaging.

Authors:  W W Woodruff; W T Djang; R E McLendon; E R Heinz; D R Voorhees
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

9.  In vivo H-1 spectroscopy in humans at 1.5 T.

Authors:  M Bárány; B G Langer; R P Glick; P N Venkatasubramanian; A C Wilbur; D G Spigos
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

10.  Combined application of MR imaging and spectroscopy in neonates and children: installation and operation of a 2.35-T system in a clinical setting.

Authors:  C Boesch; E Martin
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

View more
  5 in total

1.  Risk Factors for Perceptual-versus-Interpretative Errors in Diagnostic Neuroradiology.

Authors:  S H Patel; C L Stanton; S G Miller; J T Patrie; J N Itri; T M Shepherd
Journal:  AJNR Am J Neuroradiol       Date:  2019-07-11       Impact factor: 3.825

Review 2.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

3.  Diagnostic accuracy of MRI compared to CCT in patients with brain metastases.

Authors:  P D Schellinger; H M Meinck; A Thron
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 4.  Review of skull base surgery approaches: with special reference to pediatric patients.

Authors:  J D Kennedy; S J Haines
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.

Authors:  Nicola Marchi; Peter Mazzone; Vincent Fazio; Tarek Mekhail; Thomas Masaryk; Damir Janigro
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.